University of Wurzburg: Overcoming the Limits of Immunotherapies
August 06, 2024
August 06, 2024
WURZBURG, Germany, Aug. 6 (TNSres) -- The University of Wurzburg issued the following news release:
Dr. Karl Petri is establishing a research group at the University Hospital Wurzburg to develop and enhance novel CRISPR 2.0 tools for generating and improving cancer-targeted CAR-T cell products.
CAR-T cells are highly effective in treating selected blood cancers. However, challenges remain with this new therapy, which was first approved in 2017 in the USA and a year late . . .
Dr. Karl Petri is establishing a research group at the University Hospital Wurzburg to develop and enhance novel CRISPR 2.0 tools for generating and improving cancer-targeted CAR-T cell products.
CAR-T cells are highly effective in treating selected blood cancers. However, challenges remain with this new therapy, which was first approved in 2017 in the USA and a year late . . .